- Global Pharma News & Resources

Global Sodium Hyaluronate-based Products Market (2022 to 2030) - Share, Size, Trends, Industry Analysis Report -

DUBLIN--(BUSINESS WIRE)--The "Sodium Hyaluronate-based Products Market Share, Size, Trends, Industry Analysis Report, By Type; By Application; By Region; Segment Forecast, 2022 - 2030" report has been added to's offering.

The global sodium hyaluronate-based products market size is expected to reach USD 16.79 billion by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The key factors responsible for the industry growth include the rising prevalence of osteoarthritis and cataracts. For instance, according to the Centers for Disease Control and Prevention, the most frequent type of arthritis is osteoarthritis (OA). These alterations normally take time to manifest and worsen. Pain, stiffness, and edema are all symptoms of OA. Over 32.5 million adults in the United States suffer from OA.

Further, as per the Government of India (GOI), osteoarthritis is one of the most common rheumatologic conditions, which normally affects joints, with a prevalence rate of around 22 to 39%, in India. Women are more likely than males to develop OA. Approximately 45 percent of women over 65 have symptoms, while 70% of those over 65 have radiographic evidence of OA.

According to the World Health Organization (WHO), symptomatic osteoarthritis affects 9.6% of men and 18.0% of women over 60 worldwide. 80 percent of people with osteoarthritis have movement limitations, and 25% are unable to conduct their major daily activities.

Based on the type, the injectable segment accounted for the largest revenue share in the industry in 2021. Due to a significant wide range of applications, such as dermal fillers in aesthetic procedures, pain treatment in osteoarthritis, surgical assistance in cataract extractions, and anti-adhesives in gynecological surgeries, the injectable type segment is growing.

Companies Mentioned

  • Allergan Inc.
  • Anika Therpeutics Inc.
  • Bohus BioTech AB
  • Cadila Pharmaceuticals Ltd.
  • Ferring Pharmaceuticals B.V.
  • Fidia Farmaceutici S.p.A.
  • Galderma S.A.
  • L.G. Chem Ltd.
  • Syner-Med (Pharmaceutical Products) Ltd

The publisher has segmented the sodium hyaluronate-based products market report based on type, application, and region:

Sodium Hyaluronate-based Products, Type Outlook

  • Topical
  • Injectable
  • Others

Sodium Hyaluronate-based Products, Application Outlook

  • Pharmaceuticals
  • Opthalmology
  • Orthopedic
  • Urology
  • Others
  • Cosmetics

Sodium Hyaluronate-based Products, Regional Outlook

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • Australia
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 02-Jun-2022